⭐️ Claritas Rx Named to the 2026 Inc. 5000 List ⭐️

Read More
Get StartedSign In

News Releases

Read our official news releases and product announcements.
Inc. 5000

Claritas Rx Named to the 2026 Inc. 5000 List for the Second Consecutive Year

Recognition Marks the Company’s Second Straight Year on the Prestigious List of America’s Fastest-Growing Private Companies — and Comes as…

Read Full Post
Claritas Rx Introduces Consent Clearinghouse™ to Modernize Patient Consent Management Across Biopharma

Claritas Rx Introduces Consent Clearinghouse™ to Modernize Patient Consent Management Across Biopharma

New Solution Gives Oncology and Rare Disease Teams a Centralized, Compliant View of Patient Consent Across the Full Therapy Journey…

Read Full Post
Claritas Rx Strengthens Executive Team with New CRO and Two VP Promotions

Claritas Rx Strengthens Executive Team with New CRO and Two VP Promotions

Leadership Expansion Reflects Continued Growth and Commitment to Customer and Patient Impact  May 18, 2026 – SOUTH SAN FRANCISCO, CA – Claritas…

Read Full Post
Claritas Rx Chief Technology Officer Bhupesh Bajaj Named to PM360 ELITE 100 List

Claritas Rx Chief Technology Officer Bhupesh Bajaj Named to PM360 ELITE 100 List

Mr. Bajaj Recognized in the Data Miners Category for Transforming Complex Healthcare Data into Actionable Patient Outcomes May 12, 2026…

Read Full Post
Introducing Patient Services Omnichannel CRM from Claritas Rx

Claritas Rx Introduces Omnichannel CRM to Transform Patient Services and Speed Access to Specialty Therapies

AI-Driven Orchestration Empowers Predictive Risk Detection, Next-Best-Action (NBA) Insights and Optimized Channel, Messaging and Timing Recommendations New White Paper from…

Read Full Post
Foundational Data Aggregation

Claritas Rx Unveils Integrated Data and Consent Solution That Drives Higher First Fill Rates and Long‑Term Persistence Across Specialty and Rare Brands

New White Paper from Claritas Rx entitled “Transforming Data Aggregation in Specialty and Rare Disease” Now Available FEBRUARY 26, 2026…

Read Full Post
The Five Market Trends Shaping 2026 white paper icon

A “Data Deluge” from an Expanding Array of Data Providers is a Significant Rare Market Trend to Watch in 2026

Claritas Rx Releases New White Paper: Thriving in Turbulence: Strategic Adaptation in the Evolving Specialty and Rare Market February 11,…

Read Full Post

An Omnichannel CRM Purpose-Built for Patient Services Can Help Reduce Overall Time To Fill, Increase Fill Rates, and Drive More Patient-Months on Therapy

New White Paper from Claritas Rx entitled “Quantifying Connection: Measuring Partner Impact and CRM ROI Across the Enterprise” Now Available…

Read Full Post

HealthVerity and Claritas Rx announce strategic partnership to unlock more actionable real-world insights for commercial, RWE, and HEOR teams

PHILADELPHIA, PA, and SOUTH SAN FRANCISCO, CA – HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange,…

Read Full Post

Claritas Rx In-depth Head-to-Head Comparison of KPIs Allows Market Access Teams to Make Smarter, Data-Driven Decisions

Understanding Competitor Fill Rates, Time-to-Fill, and Physician Experience Strengthens Strategies, Improves Patient Access and Fuels Brand Growth October 6, 2025…

Read Full Post

Claritas Rx Access Analytics Delivers Real-Time Visibility Into Biopharma Brand Performance

Real-Time Channel Intelligence Empowers Smarter Market Access and Better Patient Outcomes New Thought Leadership Entitled “One Month to $241K: Real-Time…

Read Full Post

Claritas Rx Named to the 2025 Inc. 5000 List, Ranking Among America’s Fastest-Growing Private Companies

South San Francisco, CA, August 12, 2025 – Claritas Rx, the leader in intelligent solutions that provide real-time visibility across the…

Read Full Post

Claritas Rx Offers Four Strategies to Mitigate Specialty Treatment Abandonment

New White Paper Entitled “From Prescription to Abandonment: How 31% of Specialty Medications Go Unfilled Across Therapeutic Areas” Now Available…

Read Full Post

Stay Informed

Get the latest insights on patient access and pharmaceutical innovation

Subscribe

Archive

Press Contact

Members of the Media can contact Emily Brennan for interviews:

ebrennan@claritasrx.com

Stay Informed

Get the latest insights on patient access and pharmaceutical innovation